| Dr Sandra Carol Dawood, PHD | |
|
850 Keyes Ave, Angwin, CA 94508-9625 | |
| (707) 965-2673 | |
| Not Available |
| Full Name | Dr Sandra Carol Dawood |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 850 Keyes Ave, Angwin, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306181730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY12011 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sandra Carol Dawood, PHD 850 Keyes Ave, Angwin, CA 94508-9625 Ph: (707) 965-2673 | Dr Sandra Carol Dawood, PHD 850 Keyes Ave, Angwin, CA 94508-9625 Ph: (707) 965-2673 |
News Archive
Two new studies examine the use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C. The reports appear in the August issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).
Researchers have demonstrated for the first time that extracellular vesicles - tiny protein-filled structures - isolated from amniotic fluid stem cells (AFSCs) can be used to effectively slow the progression of kidney damage in mice with a type of chronic kidney disease.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Max Kamin-Cross, a self-proclaimed political junky and youth activist, writes that by improving access to contraceptives, "we could lift millions of people of all races and both genders out of poverty throughout the world," "we could significantly decrease the number of premature deaths, as well as the number of lives claimed by deadly infections like HIV," and "the quality of life for millions more people would be drastically improved."
Reata Pharmaceuticals today announced that the company will present data on the primary endpoint from a pivotal Phase 2b clinical trial of bardoxolone methyl in patients with chronic kidney disease (CKD) and type 2 diabetes. The data will be presented in a late-breaking oral presentation at the American Society of Nephrology (ASN) Renal Week Conference to be held November 16-21, 2010, in Denver, Colorado.
On Thursday in the National Academy of Medicine's Perspectives, public health leaders including CUNY Graduate School of Public Health and Health Policy Distinguished Lecturer Scott Ratzan, MD called for informed and active public policy leadership to employ strategically coordinated health communication and outreach on COVID-19 and other emerging global health threats.
› Verified 3 days ago
Dr. Aubyn Scott Fulton, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 235 Mcreynolds Dr, Angwin, CA 94508 Phone: 707-339-0133 |